BAY 77-1931
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY 77-1931, covering 2013-01-23 to 2017-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet [Phase 1]